U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202102
Company: ALEMBIC

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription AB No Yes
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription AB No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/28/2015 ORIG-1 Approval Not Applicable Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202102s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202102Orig1s000ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
01/24/2025 SUPPL-26 Labeling-Package Insert

Label is not available on this site.
01/13/2025 SUPPL-25 Labeling-Medication Guide, Labeling-Package Insert

Label is not available on this site.
02/01/2021 SUPPL-18 Labeling-Package Insert

Label is not available on this site.
02/05/2020 SUPPL-17 Labeling-Package Insert

Label is not available on this site.
02/04/2020 SUPPL-16 Labeling-Package Insert, Labeling-Medication Guide

Label is not available on this site.
03/29/2017 SUPPL-7 Labeling-Package Insert

Label is not available on this site.
03/29/2017 SUPPL-6 Labeling-Package Insert

Label is not available on this site.
08/18/2016 SUPPL-5 Labeling-Package Insert

Label is not available on this site.
03/29/2017 SUPPL-4 Labeling-Package Insert, Labeling-Container/Carton Labels

Label is not available on this site.
03/29/2017 SUPPL-2 Labeling-Package Insert

Label is not available on this site.
03/29/2017 SUPPL-1 Labeling-Container/Carton Labels, Labeling-Medication Guide

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert		 Note Url
04/28/2015 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202102s000lbl.pdf

ARIPIPRAZOLE

TABLET, ORALLY DISINTEGRATING;ORAL; 10MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 202102 ALEMBIC
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 216208 AUROBINDO PHARMA
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 202547 ORBION PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 207240 SCIEGEN PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 090165 SQUARE PHARMS

TABLET, ORALLY DISINTEGRATING;ORAL; 15MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 202102 ALEMBIC
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 216208 AUROBINDO PHARMA
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 202547 ORBION PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 207240 SCIEGEN PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET, ORALLY DISINTEGRATING;ORAL Prescription No AB 090165 SQUARE PHARMS
Back to Top